Back to products

Abevmy 100 mg Injection

Brand Name: Abevmy

Molecule: Bevacizumab

Strength: 100 mg

Quantity: 1 Vial

Form: Injection

Packaging Type: Single-use Vial

Manufacturer/Marketed By: Mylan

Country of Origin: India

Description

Abevmy 100mg Injection contains Bevacizumab, an anti-cancer monoclonal antibody used for treating various solid tumors. It works by blocking blood supply to cancer cells, slowing tumor growth and improving treatment outcomes.

Benefits

Slows tumor growth by blocking new blood vessel formation
Improves progression-free survival in many cancers
Enhances effectiveness of chemotherapy
Shown to reduce tumor vascularity
Used across multiple cancer types

Indications and Usage

Abevmy 100mg Injection is indicated for:

Metastatic colorectal cancer
Non-small cell lung cancer (NSCLC)
Ovarian, fallopian tube, and peritoneal cancer
Glioblastoma
Renal cell carcinoma
Cervical cancer

Used only under the supervision of an oncologist and administered by a healthcare professional.

How it Works

Bevacizumab targets VEGF (Vascular Endothelial Growth Factor), a protein responsible for forming blood vessels. By blocking VEGF, the medicine reduces the blood supply that tumors need to grow, effectively slowing or stopping cancer progression.

Dosage & Administration

Dose depends on body weight and cancer type
Administered as an intravenous infusion by a medical professional
Typically given every 2 or 3 weeks
Regular monitoring of blood pressure, kidney function, and overall response is essential